Biomerica, Inc. (BMRA)
Largest Insider Buys in Sector
BMRA Stock Price History Chart
BMRA Stock Performance
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely …
Insider Activity of Biomerica, Inc.
Over the last 12 months, insiders at Biomerica, Inc. have bought $0 and sold $0 worth of Biomerica, Inc. stock.
On average, over the past 5 years, insiders at Biomerica, Inc. have bought $45,752 and sold $80,878 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $310 was made by Irani Zackary S. (Chief Executive Officer) on 2023‑05‑25.
List of Insider Buy and Sell Transactions, Biomerica, Inc.
| 2023-05-25 | Chief Executive Officer | 200 0.0015% | $1.55 | $310 | -33.33% | |||
| 2023-05-24 | Chief Executive Officer | 500 0.0037% | $1.61 | $805 | -37.04% | |||
| 2023-05-12 | Chief Executive Officer | 1,700 0.0132% | $1.17 | $1,989 | -7.14% | |||
| 2023-05-10 | Chief Executive Officer | 500 0.0038% | $1.27 | $635 | -16.40% | |||
| 2023-05-09 | Chief Executive Officer | 300 0.0024% | $1.39 | $417 | -18.60% | |||
| 2023-05-04 | Chief Executive Officer | 1,000 0.0073% | $1.36 | $1,360 | -23.19% | |||
| 2023-04-28 | Chief Executive Officer | 1,800 0.0135% | $1.34 | $2,412 | -18.80% | |||
| 2023-04-27 | Chief Executive Officer | 2,600 0.0194% | $1.31 | $3,406 | -16.92% | |||
| 2023-04-26 | Chief Executive Officer | 7,000 0.0528% | $1.26 | $8,820 | -12.90% | |||
| 2023-01-27 | Executive Vice Chairman | 1,538 0.0116% | $2.94 | $4,522 | -55.86% | |||
| 2023-01-26 | director | 2,190 0.016% | $2.96 | $6,482 | -57.33% | |||
| 2023-01-25 | Chief Executive Officer | 1,800 0.013% | $2.85 | $5,130 | -55.82% | |||
| 2023-01-24 | Chief Executive Officer | 2,000 0.0149% | $2.81 | $5,620 | -53.93% | |||
| 2020-10-26 | director | 9,100 0.0773% | $5.45 | $49,595 | -8.79% | |||
| 2020-04-21 | Sale | director | 5,000 0.0429% | $8.11 | $40,532 | -16.09% | ||
| 2020-04-17 | Sale | director | 5,000 0.0419% | $8.07 | $40,346 | -17.46% | ||
| 2018-02-09 | Chief Executive Officer | 500 0.0057% | $3.83 | $1,915 | -7.18% | |||
| 2018-02-02 | Chief Executive Officer | 1,000 0.0119% | $3.96 | $3,960 | -6.68% | |||
| 2018-01-25 | Chief Executive Officer | 2,039 0.0237% | $4.03 | $8,209 | -9.16% | |||
| 2018-01-25 | director | 8,200 0.0992% | $4.18 | $34,276 | -9.16% |
Insider Historical Profitability
| Irani Zackary S. | Chief Executive Officer | 1020560 6.067% | $0.37 | 34 | 0 | <0.0001% |
| MOORE JANET TRUST DTD 8/21/98 | 635977 3.7807% | $0.37 | 1 | 0 | <0.0001% | |
| IRANI ZACKARY | Chief Executive Officer | 271526 1.6142% | $0.37 | 1 | 0 | |
| MOORE JANET | Chief Financial Officer | 140720 0.8365% | $0.37 | 2 | 6 | <0.0001% |
| CANO FRANCIS | director | 133736 0.795% | $0.37 | 7 | 0 | <0.0001% |
Institutional Investor Ownership
| Granahan Investment Management | $939,762.00 | 6.72 | 1.13M | +4.33% | +$38,979.19 | 0.03 | |
| Wasatch Advisors | $793,116.00 | 5.67 | 953,264 | 0% | +$0 | <0.01 | |
| The Vanguard Group | $506,992.00 | 3.62 | 609,365 | 0% | +$0 | <0.0001 | |
| Russell Investments Group Ltd | $187,561.00 | 1.34 | 225,435 | +11.84% | +$19,861.41 | <0.0001 | |
| BlackRock | $124,035.00 | 0.89 | 149,081 | -0.42% | -$520.83 | <0.0001 |